Advertisement
Research Article| Volume 20, ISSUE 2, P271-287, June 2000

Download started.

Ok

Diagnosis of Human Papillomavirus Gynecologic Infections

  • Myra J. Wick
    Correspondence
    Address reprint requests to: Myra J. Wick, PhD, Department of Laboratory Medicine and Pathology, 420 Delaware Street, SE, Box 609 Mayo, Minneapolis, MN 55455
    Affiliations
    From the Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30062-3
Diagnosis of Human Papillomavirus Gynecologic Infections
Previous ArticleHuman Papillomavirus in Cervical Neoplasia: Role, Risk Factors, and Implications
Next ArticleIn Situ Diagnosis of Human Papillomaviruses
      This paper is only available as a PDF. To read, Please Download here.
      The identification in the early 1980s of human papillomavirus (HPV) DNA in cervical carcinoma generated interest in molecular classification of the virus, and prompted studies regarding the oncogenic potential of genital HPVs. Subsequent studies confirming the presence of HPV in greater than 90% of precancerous cervical lesions and close to 100% of cervical cancers has raised concerns regarding the adequacy of Papanicolaou (Pap) smear testing for the detection of precancerous lesions/HPV infection. A variety of detection methods adjunctive to cytologic testing have been described, including detection at the macroscopic level, cerviography, colposcopy, and serologic and molecular-based HPV testing. Recently, there has been intense interest in molecular-based detection and typing of HPV-induced genital lesions. This has resulted in the development of a variety of molecular- based detection methods including Southern transfer, dot blotting, in situ hybridization, hybrid capture, and PCR-based assays. This article provides an overview of each of the molecular methods, and addresses the potential future role of molecular-based HPV testing.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Barrett T.J.
        • Silbar J.D.
        • McGinley J.P.
        Genital warts-a venereal disease.
        JAMA. 1954; 154: 333
        • Bauer H.M.
        • Ting Y.
        • Greer C.E.
        • et al.
        Genital human papillomavirus infection in female university students as determined by a PCR-based method.
        JAMA. 1991; 265: 472
        • Bosch F.X.
        • Manos M.M.
        • Munoz N.
        • et al.
        Prevalence of human papillomavirus in cervical cancer: A worldwide perspective.
        J Natl Cancer Inst. 1995; 87: 796
        • Burns D.A.
        Warts and all - the history and folklore of warts: A review.
        J R Soc Med. 1992; 85: 37
        • Campion M.J.
        • Reid R.
        Screening for gynecologic cancer.
        Obstet Gynecol Clin North Am. 1990; 17: 695
        • Chapman W.B.
        • Lorincz A.T.
        • Willet G.D.
        • et al.
        Evaluation of two commercially available in situ hybridization kits for the detection of human papillomavirus DNA in cervical biopsies: Comparison to Southern blot hybridization.
        Mod Pathol. 1993; 6: 73
        • Cho K.
        Cervical cancer.
        in: Vogelstein B. Kinzler K. The Genetic Basis of Human Cancer. McGraw-Hill, New York1998: 631
        • Cole H.M.
        Diagnostic and therapeutic technology assessment: Human papillomavirus DNA testing in the management of cervical neoplasia.
        JAMA. 1993; 270: 2975
        • Cope J.U.
        • Hildesheim A.
        • Schiffman M.H.
        • et al.
        Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens.
        J Clin Microbiol. 1997; 35: 2262
        • Coutlee F.
        • Mayrand M-H
        • Provencher D.
        • et al.
        The future of HPV testing in clinical laboratories and applied virology research.
        Clin Diagn Virol. 1997; 8: 123
        • Cox J.T.
        Clinical role of HPV testing.
        Obstet Gynecol Clin North Am. 1996; 23: 811
        • Cox J.T.
        • Lorincz A.T.
        • Schiffman M.H.
        • et al.
        Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.
        Am J Obstet Gynecol. 1995; 172: 946
        • Cuzik J.
        • Szarewski A.
        • Terry G.
        • et al.
        Human papillomavirus testing in primary cervical screening.
        Lancet. 1995; 17: 1533
        • Dillner J.
        • Dillner L.
        • Robb J.
        • et al.
        A synthetic peptide defines a serologic IgA response to human papillomavirus encoded nuclear antigen expressed in virus carrying cervical neoplasia.
        Proc Natl Acad Sei USA. 1989; 86: 3838
        • Dillner L.
        • Bekassy Z.
        • Jonsson N.
        • et al.
        Human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia.
        Int J Cancer. 1989; 43: 36
        • Editorial
        Histopathological grading of cervical intraepithelial neoplasia (CIN)-is there a need for change?.
        J Pathol. 1989; 159: 273
        • Ferris D.G.
        • Wright Jr, T.C.
        • Litaker M.
        • et al.
        Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL.
        J Fam Pract. 1998; 46: 136
        • Ferris D.G.
        • Wright Jr, T.C.
        • Litaker M.S.
        Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?.
        J Fam Pract. 1998; 46: 125
        • Galloway A.
        Serologic assays for the detection of HPV antibodies.
        in: Munoz N. Bosch F.X. Shah K.V. The Epidemiology of Cervical Cancer and Human Papillomavirus. France, International Agency for Research on Cancer, Lyon1992: 147
        • Gravitt P.E.
        • Manos M.M.
        Polymerase chain reaction-based methods for the detection of human papillomavirus DNA.
        in: Munoz N. Bosch F.X. Shah K.V. The Epidemiology of Cervical Cancer and Human Papillomavirus. France, International Agency for Research on Cancer, Lyon1992: 121
        • Greenberg M.D.
        • Sedlacek T.V.
        • Campion M.J.
        Cervical neoplasia: Are adjunctive tests to cervical cytology worthwhile?.
        Clin Obstet Gynecol. 1995; 38: 600
        • Gregoire L.
        • Arella M.
        • Camione-Piccardo J.
        • et al.
        Amplification of human papillomavirus DNA sequences by using conserved primers.
        J Clin Microbiol. 1989; 27: 2660
        • Harnish D.G.
        • Belland L.M.
        • Scheid E.E.
        • et al.
        Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
        Mol Cell Probes. 1999; 13: 9
        • Harper D.
        • Hildesheim A.
        • Cobb J.L.
        • et al.
        Collection devices for human papillomavirus.
        J Fam Pract. 1999; 48: 531
        • Hutchinson M.I.
        • Agarwal P.
        • Denault T.
        • et al.
        A new look at cervical cytology: ThinPrep multicenter trial results.
        Acta Cytol. 1992; 36: 499
        • Innis M.A.
        • Gelfand D.
        • Sninsky J.J.
        PCR Protocols. A Guide to Methods and Applications. Academic Press, San Diego1990
        • Jochmus-Kudielke I.
        • Schneider A.
        • Braun R.
        • et al.
        Antibodies against the human papillomavirus type 16 early proteins in sera: Correlation of anti E-7 reactivity with cervical cancer.
        J Natl Cancer Inst. 1989; 81: 1698
        • Kataja V.
        • Syrjanen K.
        • Mantyjarvi R.
        • et al.
        Prospective follow-up of cervical HPV infections: Life-table analysis of histopathological, cytological and colposcopic data.
        Eur J Epidemol. 1989; 5: 1
      29. Kistneris Gynecology: Principles and Practice. ed 6. Mosby, New York1995: 103
        • Koss L.G.
        From koilocytes to molecular biology: The impact of cytology on concepts of early human cancer.
        Mod Pathol. 1989; 2: 526
        • Kurman R.J.
        • Henson D.E.
        • Herbst A.L.
        • et al.
        Interim guidelines for management of abnormal cervical cytology.
        JAMA. 1994; 271: 1866
        • Lancaster W.D.
        • Olson C.
        Animal papillomaviruses.
        Microbiol Rev. 1982; 46: 486
        • Lorincz A.T.
        Detection of human papillomavirus DNA without amplications.
        in: Munoz N. Bosch F.X. Shah K.V. The Epidemiology of Human Papillomavirus and Cervical Cancer. France, IARC Scientific Publications, Lyon1992: 85
        • Lorincz A.T.
        Human papillomavirus detection tests.
        in: Holmes K.K. Mardh P.A. Sparling P.F. Sexually Transmitted Diseases. ed 2. McGraw-Hill, New York1990: 953
        • Lorincz A.T.
        Molecular methods for the detection of human papillomavirus infection.
        Obstet Gynecol Clin North Am. 1996; 23: 707
        • Lungu O.
        • Wright T.
        • Silverstein S.
        Typing of human papillomaviruses by polymerase chain reaction amplification with LI consensus primers and RFLP analysis.
        Mol Cell Probes. 1992; 6: 145
        • Manos M.M.
        • Ting Y.
        • Wright D.K.
        • et al.
        Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses.
        Cancer Cells. 1989; 7: 209
        • Masih A.S.
        • Stoler M.H.
        • Farrow G.M.
        • et al.
        Human papillomavirus in penile squamous cell lesions: A comparison of an isotopic RNA and two commercial noniostopic DNA in situ hybridization methods.
        Arch Pathol Lab Med. 1993; 117: 302
        • McPherson M.J.
        • Taylor G.R.
        • Quirke P.
        PCR: A Practical Approach. IRL Press, Oxford1991
        • Meisels A.
        • Fortin R.
        Condylomatous lesions of the cervix and vagina I. Cytologic patterns.
        Acta Cytol. 1976; 20: 505
        • Muller M.
        • Viscidi R.
        • Sun Y.
        • et al.
        Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16 associated invasive cancer.
        Virology. 1992; 187: 508
        • Newton C.R.
        • Graham A.
        PCR. BIOS Scientific, Oxford1994
        • Nold J.V.
        Cervical neoplasia. History-screening-diagnosis-treatment.
        SDJM. 1998; 51: 113
        • Papanicolaou G.
        • Traut H.F.
        The Diagnosis of Uterine Cancer by the Vaginal Smear. Commonwealth Fund, New York1943
        • Peyton C.L.
        • Schiffman M.
        • Lorincz A.T.
        • et al.
        Comparison of PCR-and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies.
        J Clin Microbiol. 1998; 36: 3248
        • Polijak M.
        • Brencic A.
        • Seme K.
        • et al.
        Comparative evaluation of first-and second-generation digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer.
        J Clin Microbiol. 1999; 37: 796

      47. Rasmussen KA: Verrucae Plantares: Symptomatology and Epidemiology. Copenhagen, 1958

        • Reid R.
        • Herschman B.R.
        • Crum C.P.
        • et al.
        Genital warts and cervical cancer.
        Am J Obstet Gynecol. 1984; 149: 293
        • Reid R.
        • Lorincz A.T.
        Human papillomavirus tests.
        Baillieres Clin Obstet Gynaecol. 1995; 9: 65
        • Richart R.M.
        Screening. The next century.
        Cancer. 1995; 76: 1919
        • Richart R.M.
        • Barron B.A.
        A follow-up study of patients with cervical dysplasia.
        Am J Obstet Gynecol. 1969; 105: 386
        • Schiffman M.H.
        New epidemiology of human papillomavirus infection and cervical neoplasia.
        J Natl Cancer Inst. 1995; 87: 1345
        • Schiffman M.
        • Burk R.D.
        Human papillomaviruses.
        in: Evans A. Kaslow R. Viral Infections in Humans: Epidemiology and Control. ed 4. Plenum Publishing, New York1997: 983
        • Schiffman M.H.
        • Kiviat N.B.
        • Burk R.D.
        • et al.
        Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture.
        J Clin Microbiol. 1995; 33: 545
        • Schneider A.
        • Zahm D-M
        New adjunctive methods for cervical cancer screening.
        Obstet Gynecol Clin North Am. 1996; 23: 657
        • Shah K.V.
        Genital warts, papillomaviruses, and genital malignancies.
        Annu Rev Med. 1986; 39: 371
        • Snijders P.J.
        • van den Brule A.J.
        • Schrijnemakers H.F.
        • et al.
        The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes.
        J Gen Virol. 1990; 71: 173
        • Soloman D.
        The 1988 Bethesda System for reporting cervical/vaginal cytological diagnosis.
        JAMA. 1989; 262: 931
        • Stafl A.
        Cervicography: A new method of cervical cancer detection.
        Am J Obstet Gynecol. 1981; 139: 815
        • Strickler H.D.
        • Hildescheim A.
        • Viscidi R.P.
        • et al.
        Interlaboratory agreement among results of human papillomavirus type 16 enzyme-linked immunosorbent assays.
        J Clin Microbiol. 1997; 35: 1751
        • Swygart C.
        Human papillomavirus: Disease and laboratory diagnosis.
        Br J Biomed Sei. 1997; 54: 299
        • Ting Y.
        • Manos M.M.
        Detection and typing of genital human papillomaviruses.
        in: Innis M.A. Gelfand D.H. Sninsky J.J. PCR protocols: A guide to methods and applications. Academic Press, San Diego1990: 356
        • Titus K.
        HPV test: Antidote to ASCUS headache?.
        CAP Today. 1996; 10: 30
        • van den Brule A.J.
        • Snijders P.J.
        • Gordijn R.L.
        • et al.
        General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas.
        Int J Cancer. 1990; 45: 644
        • Wright T.
        Precancerous lesions of the cervix.
        in: Kurman R. Blaustein’s Pathology of the Female Genital Tract. ed 4. Springer Verlag, New York1994: 229
        • Yoshikawa H.
        • Kawana T.
        • Kitagawa K.
        • et al.
        Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers.
        Jpn J Cancer Res. 1991; 82: 524
        • zur Hausen H.
        Papillomaviruses in human cancer.
        Cancer. 1987; 59: 1692

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30062-3

      Copyright

      © 2000 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX